Constellation Brands, Inc. (STZ) Stock Price, News, Analysis

Technical Score (1D)

SELL

News Sentiment

MIXED

STZ’s latest narrative centers on a sustained premiumization push, with the company expanding its high‑margin beer, wine, and spirits lineup to capture growing consumer willingness to pay more. This focus is expected to lift revenue and support margin expansion, positioning STZ ahead of rivals that lag in premium segments. Analysts are probing whether the new CEO’s playbook will revitalize flagship brands like Modelo Especial and Corona Extra, which have shown sluggish growth in recent quarters. Management remains confident but cautions that macro‑economic uncertainty could dampen consumer spending, underscoring the need to monitor broader economic indicators. Despite a Q1 revenue beat, the company missed EPS estimates, prompting a cautious fiscal 2027 outlook that may temper short‑term earnings expectations. UBS analysts, however, view the FY27 EPS target as attainable, citing premium portfolio strength and cost‑efficiency initiatives, which could mitigate the earnings miss. Jim Cramer’s recent “steal” endorsement highlights perceived undervaluation, but he also flags volatility and the importance of upcoming earnings guidance. The firm’s robust beer demand offsets wine and spirits weakness, yet commodity‑price pressure and margin compression remain concerns that could influence near‑term profitability. Traders should keep an eye on beer sales momentum, pricing power, and cost dynamics over the next 1–10 trading days to gauge whether the premium strategy translates into tangible earnings growth. Additionally, monitoring any updates on the share‑repurchase program and dividend policy will help assess cash‑flow allocation and potential upside.

STZ|Company Info

Sector

Consumer Defensive

Industry

Beverages - Brewers

Exchange

NYQ

Country

United States

Website

cbrands.com

Symbol

STZ

Description

Constellation Brands is a global beverage alcohol company that cultivates a diverse portfolio of leading beer, wine, and spirits brands. Its core business centers on the production, import, marketing, and sales of these beverages across the United States, Canada, Mexico, New Zealand, and Italy. The company's prominent beer brands include Corona and Modelo, while its wine offerings feature labels such as Kim Crawford and Robert Mondavi Winery. Constellation Brands also boasts a spirits portfolio with brands like SVEDKA and High West. Distribution channels encompass wholesale distributors, retailers, on-premise establishments, and government agencies, solidifying its market reach.

STZ|Earnings Snapshot

Earnings Summary

Constellation Brands (STZ) is a global beverage alcohol company that markets a diversified portfolio of beer, wine, and spirits brands such as Corona, Modelo, Kim Crawford, and SVEDKA across North America, New Zealand, and Italy, operating within the consumer‑defensive beverages‑brewers sector. In recent quarters, the company posted a Q1 2025 EPS of $2.63 versus an estimate of $2.27 and revenue of $2.164 billion, beating consensus; the Q2 2025 EPS of $3.22 fell short of the $3.30 estimate despite revenue of $2.515 billion, and the Q3 2025 EPS of $3.63 beat the $3.41 estimate with revenue of $2.481 billion. The Q4 2025 EPS of $3.06 surpassed the $2.63 estimate while revenue of $2.222 billion was slightly lower than the $2.515 billion in Q2 2025, indicating a modest revenue decline. In the most recent fiscal year, Q3 2026 EPS rose to $3.06 against a $1.68 estimate and revenue of $2.222 billion, but Q4 2026 EPS fell to $1.90 versus a $1.71 estimate with revenue of $1.920 billion, reflecting a sharp earnings contraction. Over the past six quarters the company has shown a mixed earnings trajectory, with four EPS beats and two misses, while revenue peaked in Q2 2025 and has since declined, suggesting a potential shift in demand dynamics. Recent news highlights the firm’s premiumization strategy, with new product innovation aimed at sustaining growth, though analysts note sluggish momentum in flagship brands; the company’s Q1 FY27 results beat revenue estimates but missed EPS, raising concerns about margin compression. Investors should watch for the upcoming earnings release to gauge the effectiveness of the premium push, monitor cost‑inflation impacts on margins, and assess the progress of direct‑to‑consumer initiatives, as these factors will determine whether the company can translate top‑line growth into sustainable profitability.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q1'27	$3.61	-	-
Q4'26	$1.71	$1.90	+10.9%
Q3'26	$1.68	$3.06	+81.6%
Q4'25	$2.63	$3.06	+16.2%
Q3'25	$3.41	$3.63	+6.5%
Q2'25	$3.29	$3.22	-2.3%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q1'27	$2.5B	-	-
Q4'26	$1.9B	$1.9B	+2.3%
Q3'26	$1.8B	$2.2B	+20.5%
Q4'25	-	$2.2B	-
Q3'25	-	$2.5B	-
Q2'25	-	$2.5B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

STZ Stock Snapshot

STZ is currently trading at $130.92, giving Constellation Brands, Inc. a market cap of 22.63B and a P/E ratio of 12.4. Today's range spans $130.65–$134.48, with shares opening at $133.08 and moving down $3.44 (2.6%) from the prior close. DailyIQ's technical score sits at 18/100 (SELL) with a news sentiment reading of 46/100.

Over the past year STZ has traded between $126.45 and $178.14 - the current price is +3.5% off the 52-week low and -26.5% from the high. 29 analysts cover the stock with a Buy consensus and a mean 12-month target of $171.00 (range $115.00–$209.00), implying upside of +30.6%.

The path of least resistance for Constellation Brands, Inc. (STZ) is currently lower - 18/100 (SELL), neutral sentiment (46/100), price $130.92 (near 52-week lows within $126.45–$178.14). The current P/E ratio stands at 12.4. At 22.63B in Consumer Defensive market cap, this large-cap name is in the zone where portfolio risk managers - not just traders - are making decisions. Trimming positions on technical deterioration is standard practice at this size, and the current setup gives them a clear rationale to act.

The current SELL phase for STZ (18/100) at $130.92 (near 52-week lows) suggests that the market is discounting either a fundamental deterioration or a sector headwind that hasn't fully appeared in the earnings line yet. Sentiment at 46/100 (neutral) confirms that news flow is not providing a counternarrative. At 22.63B in Consumer Defensive capitalization, STZ has the liquidity for institutional exits to be orderly — but orderly doesn't mean shallow within the $126.45–$178.14 range.

News Sentiment Analysis

Sentiment gathered from recent headlines

46/100

Strong NegativeNeutralStrong Positive

MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Barclays has reduced its price target for Constellation Brands (STZ) from $139 to $132 while keeping an equalweight rating. The analyst consensus remains overweight, with a mean target of $170.73 per FactSet. The downgrade reflects concerns over the company’s near‑term earnings outlook and broader market conditions. Traders should monitor the upcoming earnings release and any guidance updates for potential catalysts.

What did this article say?

Constellation Brands (STZ) continues to strengthen its position in the beer, wine, and spirits markets by focusing on premiumization and a high‑margin portfolio. The company’s flagship beer brands—Modelo, Corona, and Pacifico—remain key growth engines, supported by direct‑to‑consumer capabilities and an expanding global footprint. STZ’s strategy centers on product innovation and leveraging evolving consumer preferences to capture opportunities in fast‑growing segments. The firm’s portfolio includes premium wine labels such as Robert Mondavi, Kim Crawford, and High West, further diversifying revenue streams. Investors should monitor the company’s ongoing investment in power brands and its ability to sustain margin expansion amid competitive pressures.

What did this article say?

Analysts focused on Constellation Brands’ (STZ) new playbook for its flagship beer brands. They questioned whether the new CEO’s strategy will revive Modelo Especial and Corona Extra, which have seen sluggish growth. Management expressed confidence in the plan but highlighted economic uncertainty affecting consumer spending. The discussion underscores the need to monitor brand performance and macro‑economic trends for future earnings.

What did this article say?

Constellation Brands reported a revenue beat for fiscal Q1 2027 but missed EPS estimates. The company raised its full‑year outlook despite the earnings miss. Shares remain near multi‑year lows, supported by beer growth and ongoing buybacks.

What did this article say?

Jim Cramer on Mad Money praised Constellation Brands (STZ) as a bargain after the company reported earnings that appear to have bottomed, especially in beer. He highlighted AI and neocloud opportunities that could drive future growth. Cramer noted the stock’s 3 % yield and suggested it is a good entry point for investors with higher risk tolerance. The commentary underscores a potential upside if earnings continue to improve and demand for beer remains resilient.

What did this article say?

Constellation Brands (STZ) is under scrutiny following its latest earnings release, with analysts questioning the company’s growth trajectory and margin sustainability. The company’s revenue growth has slowed, and operating margins have compressed, raising concerns about future profitability. Investors are weighing whether the current valuation reflects these risks or if the stock remains undervalued relative to peers.

What did this article say?

Constellation Brands (STZ) benefits from a robust beer segment, with first‑quarter fiscal 2027 net sales up 2% to $2.28 billion, driven by shipment volume growth and pricing gains. Premium wine and spirits brands are still in a reset phase following portfolio adjustments, creating some margin pressure. Management emphasizes consumer insights, occasion‑based marketing, and disciplined investment to maintain relevance across its scaled brands. Investors should monitor how cost‑saving initiatives and tariff impacts affect the company’s overall profitability.

What did this article say?

STZ trades at a discounted valuation relative to peers, yet its future depends on beer performance outpacing wine and spirits weakness. The firm’s cautious fiscal 2027 guidance signals potential earnings pressure. Market participants should watch for any shift in beer sales momentum and the company’s ability to maintain margins. The valuation discount may present a value play if beer strength materializes. However, persistent weakness in wine and spirits could undermine upside.

What did this article say?

STZ’s beer segment remains the primary growth engine, compensating for declining wine and spirits volumes. The company’s fiscal 2027 outlook remains cautious, reflecting uncertainty in the broader alcohol sector. Strong beer sales and margin preservation are key to sustaining earnings growth. Traders should track beer sales data, pricing power, and cost inflation. The company’s ability to leverage its beer portfolio will be critical for future performance.

What did this article say?

Jim Cramer praised Constellation Brands (STZ) as a 'steal' following its recent share price decline. The analyst highlighted the company's robust portfolio and solid fundamentals as reasons for a strong buy recommendation. Investors should monitor STZ's upcoming earnings release and any guidance on margin expansion.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

STZ·Constellation Brands, Inc.

EPS

Revenue

STZ Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More